Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVES-IBD: Aspirin for VTE Prophylaxis in IBD Surgery
NCT05104229Phase 3Withdrawn
- Start
- Jun 2024
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in venous thromboembolism (VTE). Planned start Jun 2024; status: withdrawn.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT05104229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05104229.